Sweden· SE-20240522000179
Selexipag Accord 1000 mikrogram Filmdragerad tablett
A medicinal product containing selexipag, registered in Sweden by Accord Healthcare B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Selexipag
- Manufacturer
- Accord Healthcare B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240522000179
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Selexipag in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandSelexipag AccordAccord Healthcare Polska Sp. z o.o.
- CzechiaSELEXIPAG ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- NetherlandsSelexipag Teva 1000 microgram, filmomhulde tablettenTeva GmbH
- United StatesSelexipagZydus Lifesciences Limited
- SpainSELEXIPAG ACCORD 1000 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- IrelandSelexipag Clonmel 1000 microgram film-coated tabletsClonmel Healthcare Ltd
- NorwayUptraviJanssen-Cilag International N.V.
- FinlandUptraviJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Selexipag Ratiopharm
- Cyprus · Selexipag Accord
- Denmark · Selexipag Accord, Selexipag Stada
- Estonia · Selexipag Stada
- Spain · Selexipag Accord, Selexipag Stada
- Greece · Xipeno
- Croatia · Seleksipag Accord
- Ireland · Selexipag Accord, Selexipag Clonmel
- Iceland · Selexipag Stada, Uptravi
- Italy · Selexipag Accord, Selexipag Eg
- Liechtenstein · Uptravi
- Lithuania · Selexipag Stada
- Latvia · Selexipag Stada
- Malta · Selexipag Clonmel
- Netherlands · Seleksipag Accord, Selexipag Abdi
- Norway · Selexipag Accord, Selexipag Stada
- Poland · Selexipag, Selexipag Accord
- Portugal · Selexipag Accord, Selexipag Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5439d2c2-f5a4-427f-a618-e904d994ba0f GET /v1/drugs/5439d2c2-f5a4-427f-a618-e904d994ba0f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20240522000179",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240522000179",
"product_doc_link": "https://docetp.mpa.se/LMF/Selexipag%20Accord%20film-coated%20tablet%20SmPC_09001bee84c2a2ca.pdf"
}See everything about selexipag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.